Review: could Rebif cause Muscle Spasticity?


Summary

Muscle spasticity is found among people who take Rebif, especially for people who are female, 40-49 old , have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Multiple sclerosis . We study 31,189 people who have side effects while taking Rebif from FDA and social media. Among them, 159 have Muscle spasticity. Find out below who they are, when they have Muscle spasticity and more.

You are not alone

Join a support group for people who take Rebif and have Muscle spasticity >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Rebif

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. (latest outcomes from Rebif 31,281 users)

Muscle Spasticity

Muscle spasticity (tight or stiff muscles and an inability to control those muscles) has been reported by people with muscle spasms, death, pain, drowsiness, drug withdrawal syndrome (latest reports from 14,644 Muscle spasticity patients).

On Jul, 23, 2016

31,189 people reported to have side effects when taking Rebif.
Among them, 159 people (0.51%) have Muscle Spasticity


Number of reports submitted per year:

Could Rebif cause Muscle spasticity?

Time on Rebif when people have Muscle Spasticity *:

  • < 1 month: 9.09 %
  • 1 - 6 months: 15.91 %
  • 6 - 12 months: 9.09 %
  • 1 - 2 years: 15.91 %
  • 2 - 5 years: 38.64 %
  • 5 - 10 years: 6.82 %
  • 10+ years: 4.55 %

Gender of people who have Muscle Spasticity when taking Rebif *:

  • female: 76.1 %
  • male: 23.9 %

Age of people who have Muscle Spasticity when taking Rebif *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.72 %
  • 20-29: 9.35 %
  • 30-39: 24.46 %
  • 40-49: 26.62 %
  • 50-59: 25.18 %
  • 60+: 13.67 %

Top conditions involved for these people *:

  • Multiple Sclerosis (111 people)
  • Relapsing-Remitting Multiple Sclerosis (12 people)
  • Depression (6 people)
  • Secondary Progressive Multiple Sclerosis (5 people)
  • Muscle Spasticity (4 people)

Top co-used drugs for these people *:

  • Baclofen (28 people)
  • Ibuprofen (12 people)
  • Tylenol (7 people)
  • Amantadine Hcl (7 people)
  • Neurontin (6 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Muscle spasticity when taking Rebif?

Browse all side effects of Rebif

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Muscle spasticity

Muscle spasticity

Could your condition cause Muscle spasticity

Muscle spasticity

Can you answer these questions?

More questions for: Rebif, Muscle spasticity

You may be interested in these reviews

More reviews for: Rebif, Muscle spasticity


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.